Last reviewed · How we verify
NCT07117539: PLIAP
Impact of Different Lung Isolation Devices on Pharyngolaryngeal Injuries After Pulmonary Resection
NA trial testing visual bronchial blocker (VBB) in Pulmonary Neoplasm in 270 participants. Completed in 30 November 2025.
31 October 2025
Quick facts
| Lead sponsor | Tingting Li |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 270 |
| Start date | 18 August 2025 |
| Primary completion | 31 October 2025 |
| Estimated completion | 30 November 2025 |
| Sites | 3 locations across China |
Drugs / interventions tested
- visual bronchial blocker (VBB)
- double-lumen endotracheal tube (DLT)
Conditions studied
- Pulmonary Neoplasm — all drugs for Pulmonary Neoplasm →
Sponsor
Tingting Li
Who can join
18 and older, any sex, with Pulmonary Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to assess the impact of laryngeal mask combined with visual bronchial blocker on pharyngolaryngeal injury after pulmonary resection in patients with pulmonary nodules. The main question it aims to answer is: the incidence of postoperative pharyngolaryngeal injury within 24h : sore throat and hoarseness ? Researchers will compare the visual bronchial blocker group (VBB) with the double-lumen endotracheal tube group (DLT) to see if the visual bronchial blocker group can minimize laryngopharyngeal injury after pulmonary resection.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Laryngeal mask airway combined with visual bronchial blocker versus double-lumen tube for lung isolation in video-assisted thoracoscopic surgery: a protocol for a multicentre randomised controlled trial.
Zhang Y, Li T, Wei J, Bao R, et al · · 2025 · PMID 41469076 · DOI 10.1136/bmjopen-2025-110539
Verify or expand the search:
- PubMed search for NCT07117539
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pulmonary Neoplasm
Currently open trials in the same condition.
- NCT06546007 — Rarecells Molecular Biomarkers for Early Detection of Lung Cancer · recruiting
- NCT05857995 — Precision Lung Cancer Survivorship Care Intervention · NA · recruiting
- NCT06412172 — The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP) · recruiting
- NCT05521789 — Erector Spinae Block for Thoracic Surgery · Phase 4 · recruiting
- NCT04945928 — Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07117539 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tingting Li
- Last refreshed: 15 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07117539.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing